Condition
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma clinical trials and research
Research outlook What's coming for Stomach cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in China (2), Belgium (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SHR-1701 with chemotherapy for gastric/GEJ cancer with peritoneal spread | Phase 2 | Shanghai, Shanghai Municipality and 1 other locations | Recruiting | Feb 3, 2026 |
| Zolbetuximab with paclitaxel and ramucirumab for CLDN18.2-positive stomach and gastro‑esophageal junction cancer | Phase 2 | Antwerp and 5 other locations | Recruiting | May 8, 2025 |
| Testing AK109 and AK104 for advanced stomach cancer treatment | Phase 1/2 | Beijing | Recruiting | Jul 29, 2021 |
All recruiting trials (3)
-
SHR-1701 with chemotherapy for gastric/GEJ cancer with peritoneal spread
This study tests whether SHR-1701 plus either paclitaxel-based therapy with intraperitoneal and intravenous delivery or CAPOX can help adults with gastric or GEJ adenocarcinoma that has spread to the peritoneum.
-
Zolbetuximab with paclitaxel and ramucirumab for CLDN18.2-positive stomach and gastro‑esophageal junction cancer
This treatment tests whether adding zolbetuximab to paclitaxel and ramucirumab helps adults with metastatic gastro‑esophageal adenocarcinoma whose tumors are CLDN18.2‑positive live longer.
-
Testing AK109 and AK104 for advanced stomach cancer treatment
This study is testing two new treatments, AK109 and AK104, to see if they can help people with advanced stomach cancer who haven't had success with other therapies.
Related topics
Quick answers
How many Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.